stars 1 stars 2 stars 3

Established in August 2000, Biotoxtech Co., Ltd. (Biotoxtech) is a non-clinical Contract Research Organization based in Chungcheongbuk-do, South Korea. Biotoxtech serves domestic and international clients and has submitted hundreds of documents to numerous international regulatory agencies including within the US, Japan and Europe for new compounds, as well as performing the most GLP certified non-clinical GLP studies in Korea. Biotoxtech is the only CRO to be KOSDAQ listed in Korea and was the first organization in Asia to receive Full AAALAC Accreditation. Furthermore, Biotoxtech has received Korea's first accreditations in safety pharmacology and alternatives to animal testing. In January 2015, Biotoxtech was the first domestic private non-clinical testing institution to receive GLP accreditation from the US FDA. Biotoxtech established a joint venture company, SCAS-BTT Bioanalysis Co., Ltd. (SBB), with Japan's Sumika Chemical Analysis Service to support the toxicokinetics/ pharmacokinetics sector.

Biotoxtech Co., Ltd. Questions

The Biotoxtech Co., Ltd. annual revenue was $29 million in 2026.

5 people are employed at Biotoxtech Co., Ltd..

Biotoxtech Co., Ltd. is based in Chungcheongbuk-do, Chungcheongbuk-do.

The NAICS codes for Biotoxtech Co., Ltd. are [316, 316998, 3169, 31699, 31].

The SIC codes for Biotoxtech Co., Ltd. are [319, 31].

Top Biotoxtech Co., Ltd. Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users